Juying Wei
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Hematology 26
- Acute Myeloid Leukemia Research 19
- Multiple Myeloma Research and Treatments 3
- Autoimmune and Inflammatory Disorders Research 3
-
- Lymphoma Diagnosis and Treatment 17
- Co-authors
- Wenbin Qian (12 shared papers)Jie Jin (25 shared papers)Liping Mao (16 shared papers)Chaoting Zhang (1 shared paper)Zhilu Chen (1 shared paper)Qunyi Guo (1 shared paper)Wen Lei (1 shared paper)Chunmei Yang (3 shared papers)
- Journals
- Blood (5 papers)Journal of Hematology & Oncology (3 papers)British Journal of Haematology (3 papers)Annals of Hematology (3 papers)Experimental Hematology and Oncology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Juying Wei
54 papers receiving 639 citations
Peers
Comparison fields: 5 of 49
- Hematology 201
- Oncology 196
- Pathology and Forensic Medicine 90
- Molecular Medicine 18
- Microbiology 2
Countries citing papers authored by Juying Wei
This map shows the geographic impact of Juying Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juying Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juying Wei more than expected).
Fields of papers citing papers by Juying Wei
This network shows the impact of papers produced by Juying Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juying Wei. The network helps show where Juying Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Juying Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 128 | |
| 2 | 2022 | 85 | |
| 3 | 2017 | 36 | |
| 4 | 2015 | 28 | |
| 5 | 2018 | 24 | |
| 6 | 2018 | 23 | |
| 7 | 2021 | 23 | |
| 8 | 2020 | 21 | |
| 9 | 2017 | 20 | |
| 10 | 2022 | 20 | |
| 11 | 2012 | 18 | |
| 12 | 2018 | 14 | |
| 13 | 2019 | 14 | |
| 14 | Bortezomib in treatment of extramedullary plasmacytoma of the pancreas. | 2009 | 13 |
| 15 | 2020 | 12 | |
| 16 | 2010 | 11 | |
| 17 | 2023 | 11 | |
| 18 | 2017 | 10 | |
| 19 | 2020 | 10 | |
| 20 | 2022 | 10 |
About Juying Wei
Juying Wei is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Epidemiology and Public Health, Environmental and Occupational Health, having authored 61 papers that have together received 648 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (17 papers), Viral-associated cancers and disorders (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Multiple Myeloma Research and Treatments (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers), CAR-T cell therapy research (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Hematology (201 citations), Oncology (196 citations), Pathology and Forensic Medicine (90 citations), Molecular Medicine (18 citations) and Microbiology (2 citations). Juying Wei has collaborated with scholars based in China and United States. Frequent co-authors include Wenbin Qian, Jie Jin, Liping Mao, Chaoting Zhang, Zhilu Chen, Qunyi Guo, Wen Lei, Chunmei Yang, Ying Lu and Zheming Lu. Their work appears in journals such as Blood, Journal of Hematology & Oncology, British Journal of Haematology, Annals of Hematology and Experimental Hematology and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.